5646 Organometallics, Vol. 27, No. 21, 2008
Gao et al.
none and distilled under argon prior to use. Methylaluminoxane
(MAO, a 1.46 M solution in toluene) and modified methylalumi-
noxane (MMAO, 1.93 M in heptane, 3A) were purchased from
Akzo Nobel Corp. Diethylaluminum chloride (Et2AlCl2, 1.7 M in
toluene) was purchased from Acros Chemicals. Other reagents were
purchased from Aldrich or Acros Chemicals. 1H and 13C NMR
spectra were recorded on a Bruker DMX 300 or 400 MHz
instrument at ambient temperature using TMS as an internal
standard. FT-IR spectra were recorded on a Perkin-Elmer System
2000 FT-IR spectrometer. Elemental analyses were carried out using
a Flash EA 1112 microanalyzer. GC analyses were performed with
a Varian CP-3800 gas chromatograph equipped with a flame
ionization detector and a 30 m (0.2 mm i.d., 0.25 µm film thickness)
CP-Sil 5 CB column. The yields of oligomers were calculated by
referencing with the mass of the solvent, on the basis of the
prerequisite that the mass of each fraction was approximately
proportional to its integrated areas in the GC trace. Selectivity for
the R-C4 was defined as (amount of R-C4)/(total amounts of C4) in
percent.
4.2. Syntheses and Characterization. 2,6-Dimethyl-N-(1-(6-
(benzo[d]oxazol-2-yl)pyridin-2-yl)ethylidene)benzenamine (L1). A
solution of 2-(2-benzoxazole)-6-acetylpyridine (0.95 g, 4 mmol),
2,6-dimethylaniline (0.67 g, 4.8 mmol), and a catalytic amount of
p-toluenesulfonic acid in toluene (50 mL) was refluxed for 24 h.
After solvent evaporation, the crude product was purified with
petroleum ether/ethyl acetate (v/v ) 20:1) on an alumina column.
The second part to elute was collected and concentrated to give a
yellow powder (0.70 g, 51% yield). Mp: 136-137 °C. FT-IR (KBr
disk, cm-1): 3069, 1644 (νCdN), 1581, 1552, 1453, 1365, 1245,
1208, 1155, 1110, 1092, 1075, 823, 762. 1H NMR (400 MHz,
CDCl3, TMS): δ 8.56 (d, 1H, J ) 7.9, Py, Hm), 8.45 (d, 1H, J )
7.7, Py, Hm), 8.02 (t, 1H, J ) 7.9, Py, Hp), 7.88-7.86 (m, 1H, Ar
H), 7.70-7.68 (m, 1H, Ar H), 7.45-7.39 (m, 2H, Ar H), 7.09 (d,
2H, J ) 7.5, Ar H), 6.96 (t, 1H, J ) 7.4, Ar H), 2.36 (s, 3H, CH3),
2.06 (s, 6H, 2 × CH3). 13C NMR (300 MHz, CDCl3, TMS): δ
167.0, 156.9, 151.1, 148.6, 145.2, 141.9, 137.4, 128.0, 126.0, 125.3,
124.9, 124.7, 123.2, 120.8, 111.2, 18.0, 16.7. Anal. Calcd for
C22H19N3O (341.41): C, 77.40; H, 5.61; N, 12.31. Found: C, 77.21;
H, 5.64; N, 12.42.
126.0, 124.9, 124.7, 123.7, 123.2, 123.0, 120.7, 111.2, 28.3, 23.2,
22.9, 17.3. Anal. Calcd for C26H27N3O (397.51): C, 78.56; H, 6.85;
N, 10.57. Found: C, 78.32; H, 6.67; N, 10.54.
2,6-Dichloro-N-(1-(6-(benzo[d]oxazol-2-yl)pyridin-2-yl)ethyl-
idene)benzenamine (L4). A solution of 2-(2-benzoxazole)-6-
acetylpyridine (0.72 g, 3 mmol), 2,6-dichoroaniline (0.64 g, 3.9
mmol), and a catalytic amount of p-toluenesulfonic acid in tetraethyl
silicate in toluene solvent (3 mL) was refluxed for 24 h. After
solvent evaporation, the crude product was purified with petroleum
ether/ethyl acetate (v/v ) 20:1) on an alumina column. The second
part to elute was collected and concentrated to give a white powder
in 12.0% yield. Mp: 170-171 °C. FT-IR (KBr disk, cm-1): 3066,
1646 (νCdN), 1585, 1550, 1454, 1434, 1367, 1245, 1225, 1155,
1116, 1077, 786, 767, 745. 1H NMR (400 MHz, CDCl3, TMS): δ
8.56 (d, 1H, J ) 7.8, Py, Hm), 8.48 (d, 1H, J ) 7.7, Py, Hm), 8.03
(t, 1H, J ) 7.8, Py, Hp), 7.89-7.86 (m, 1H, Ar H), 7.70-7.68 (m,
1H, Ar H), 7.46-7.40 (m, 2H, Ar H), 7.37 (d, 2H, J ) 8.0, Ar H),
7.02 (t, 1H, J ) 8.0, Ar H), 2.48 (s, 3H, CH3). 13C NMR (300
MHz, CDCl3, TMS): δ 170.5, 160.7, 155.4, 150.4, 144.8, 144.6,
141.2, 137.0, 127.6, 125.4, 124.6, 124.3, 123.9, 123.8, 123.2, 120.1,
110.5, 17.1. Anal. Calcd for C20H13Cl2N3O (382.24): C, 62.84; H,
3.43; N, 10.99. Found: C, 62.72; H, 3.44; N, 11.02.
2,6-Dibromo-N-(1-(6-(benzo[d]oxazol-2-yl)pyridin-2-yl)ethyl-
idene)benzenamine (L5). Using the same procedure as for the
synthesis of L4, L5 was obtained as a white powder in 43% yield.
Mp: 169-170 °C. FT-IR (KBr disk, cm-1): 3063, 1647 (νCdN),
1583, 1549, 1454, 1432, 1402, 1368, 1243, 1223, 1153, 1120, 1093,
1076, 853, 762. 1H NMR (400 MHz, CDCl3, TMS): δ 8.58 (d,
1H, J ) 7.8, Py, Hm), 8.49 (d, 1H, J ) 7.8, Py, Hm), 8.04 (t, 1H,
J ) 7.8, Py, Hp), 7.89-7.87 (m, 1H, Ar H), 7.71-7.68 (m, 1H, Ar
H), 7.59 (d, 2H, J ) 8.1, Ar H), 7.46-7.40 (m, 2H, Ar H), 6.88 (t,
1H, J ) 8.0, Ar H), 2.47 (s, 3H, CH3). 13C NMR (400 MHz, CDCl3,
TMS): δ 171.1, 161.5, 156.1, 151.2, 148.1, 145.5, 142.0, 137.8,
132.1, 126.2, 125.6, 125.4, 125.1, 124.0, 120.9, 113.6, 111.3, 18.0.
Anal. Calcd for C20H13Br2N3O (471.14): C, 50.99; H, 2.78; N, 8.92.
Found: C, 50.84; H, 2.84; N, 8.69.
2,4,6-Trimethyl-N-(1-(6-(benzo[d]oxazol-2-yl)pyridin-2-yl)-
ethylidene)benzenamine (L6). Using the same procedure as for the
synthesis of L1, L6 was obtained as a yellow powder in 57% yield.
Mp: 150-151 °C. FT-IR (KBr disk, cm-1): 3069, 1645(νCdN),
1550, 1479, 1453, 1364, 1245, 1215, 1146, 1116, 1074, 850, 822,
2,6-Diethyl-N-(1-(6-(benzo[d]oxazol-2-yl)pyridin-2-yl)ethyl-
idene)benzenamine (L2). Using the same procedure as for the
synthesis of L1, L2 was obtained as a yellow powder in 69% yield.
Mp: 123-124 °C. FT-IR (KBr disk, cm-1): 2966, 1651 (νCdN),
1584, 1569, 1551, 1455, 1403, 1364, 1326, 1244, 1200, 1156, 1115,
1074, 855, 752. 1H NMR (300 MHz, CDCl3, TMS): δ 8.55 (d,
1H, J ) 7.9, Py, Hm), 8.45 (d, 1H, J ) 7.8, Py, Hm), 8.01 (t, 1H,
J ) 7.9, Py, Hp), 7.87-7.85 (m, 1H, Ar H), 7.72-7.66 (m, 1H, Ar
H), 7.46-7.38 (m, 2H, Ar H), 7.13 (d, 2H, J ) 7.6, Ar H),
7.08-6.96 (m, 1H, Ar H), 2.42 (q, 2H, J ) 7.8, CH2), 2.37 (s, 3H,
CH3), 2.34 (q, 2H, CH2), 1.15 (t, 6H, J ) 6.5, 2 × CH3). 13C NMR
(400 MHz, CDCl3, TMS): δ 166.2, 161.1, 156.4, 150.6, 147.2,
144.7, 141.4, 137.0, 130.6, 127.1, 125.5, 124.5, 124.2, 123.1, 122.6,
120.3, 117.8, 110.7, 24.2, 16.6, 13.3. Anal. Calcd for C24H23N3O
(369.46): C, 78.02; H, 6.27; N, 11.37. Found: C, 77.82; H, 6.24;
N, 11.43.
1
744. H NMR (400 MHz, CDCl3, TMS): δ 8.55 (d, 1H, J ) 7.9,
Py, Hm), 8.44 (d, 1H, J ) 7.6, Py, Hm), 8.00 (t, 1H, J ) 7.8, Py,
Hp), 7.88-7.86 (m, 1H, Ar H), 7.70-7.68 (m, 1H, Ar H),
7.46-7.39 (m, 2H, Ar H), 6.91 (s, 2H, Ar H), 2.35 (s, 3H, CH3),
2.30 (s, 3H, CH3), 2.02 (s, 6H, 2 × CH3). 13C NMR (400 MHz,
CDCl3, TMS): δ 167.3, 161.7, 157.2, 151.2, 146.2, 145.3, 142.0,
137.6, 132.5, 129.0, 128.8, 126.1, 125.3, 125.1, 124.8, 123.3, 120.9,
111.3, 20.9, 18.0, 16.8. Anal. Calcd for C23H21N3O (355.43): C,
77.72; H, 5.96; N, 11.82. Found: C, 77.64; H, 6.02; N, 11.88.
4-Bromo-2,6-dimethyl-N-(1-(6-(benzo[d]oxazol-2-yl)pyridin-
2-yl)ethylidene)benzenamine (L7). Using the same procedure as
for the synthesis of L1, L7 was obtained as a yellow powder in
56% yield. Mp: 170-171 °C. FT-IR (KBr disk, cm-1): 2924, 1642
(νCdN), 1583, 1554, 1453, 1365, 1244, 1207, 1154, 1108, 1074,
1
2,6-Diisopropyl-N-(1-(6-(benzo[d]oxazol-2-yl)pyridin-2-yl)-
ethylidene)benzenamine (L3). Using the same procedure as for
the synthesis of L1, L3 was obtained as a yellow powder in 50%
yield. Mp: 159-160 °C. FT-IR (KBr disk, cm-1): 2964, 1651
(νCdN), 1586, 1550, 1456, 1366, 1324, 1242, 1190, 1116, 1076,
766, 751, 670. 1H NMR (400 MHz, CDCl3, TMS): δ 8.56 (d, 1H,
J ) 7.9, Py, Hm), 8.45 (d, 1H, J ) 7.8, Py, Hm), 8.01 (t, 1H, J )
7.9, Py, Hp), 7.89-7.86 (m, 1H, Ar H), 7.70-7.67 (m, 1H, Ar H),
7.46-7.38 (m, 2H, Ar H), 7.21-7.18 (m, 2H, Ar H), 7.14-7.09
(m, 1H, Ar H), 2.81-2.74 (m, 2H, 2 × CH), 2.40 (s, 3H, CH3),
1.18-1.15 (m, 12H, 4 × CH3). 13C NMR (400 MHz, CDCl3, TMS):
δ 166.7, 161.5, 156.8, 151.0, 146.2, 145.1, 141.8, 137.5, 135.7,
835, 744. H NMR (400 MHz, CDCl3, TMS): δ 8.52 (d, 1H, J )
7.9, Py, Hm), 8.45 (d, 1H, J ) 7.6, Py, Hm), 8.01 (t, 1H, J ) 7.8,
Py, Hp), 7.88-7.86 (m, 1H, Ar H), 7.70-7.67 (m, 1H, Ar H),
7.46-7.39 (m, 2H, Ar H), 7.23 (s, 2H, Ar H), 2.35 (s, 3H, CH3),
2.02 (s, 6H, 2 × CH3). 13C NMR (400 MHz, CDCl3, TMS): δ
167.9, 161.6, 156.7, 151.2, 147.8, 145.4, 142.0, 137.6, 130.7 × 3,
127.8 × 2, 126.2, 125.0, 123.3, 120.9, 115.9, 111.3, 17.9 × 2, 17.0.
Anal. Calcd for C22H18BrN3O (420.30): C, 62.87; H, 4.32; N, 10.00.
Found: C, 62.47; H, 4.54; N, 10.38.
4.3. Synthesis of Nickel Complexes. General Procedure: A
solution of NiCl2 · 6H2O in ethanol or (DME)NiBr2 in THF was
added dropwise to a solution of the corresponding ligand in ethanol